Insider Transactions in Q4 2025 at Allogene Therapeutics, Inc. (ALLO)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 18
2025
|
Joshua A Kazam Director |
BUY
Exercise of conversion of derivative security
|
Direct |
47,700
+11.97%
|
-
|
|
Nov 17
2025
|
Benjamin Machinas Beneski SVP, Chief Technical Officer |
SELL
Open market or private sale
|
Direct |
786
-0.36%
|
$786
$1.22 P/Share
|
|
Oct 21
2025
|
Geoffrey M. Parker CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
36,744
-2.8%
|
$36,744
$1.26 P/Share
|